Asia-Pacific

Asia-Pacific. The opportunity is growing. So is the complexity.

APAC’s impact is no longer regional. It is redefining how innovative therapies
move from development to global markets. What does it take to turn APAC’s
emerging opportunities into strategic advantage?

Commercialization & Access

China Market Access After NRDL Maturity: What Comes After the Price Reset?

Commercialization & Access | White Paper China Market Access After NRDL Maturity: What Comes After the Price Reset? NRDL inclusion is no longer the finish line. See why reimbursement alone doesn’t guarantee real-world utilization.

The Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Markets Image

Commercialization & Access | White Paper The Role of Societal Value Analyses in Supporting Access to Novel Pharmacotherapies in Asia-Pacific Markets See how looking beyond clinical value can strengthen your case with payers and policymakers.

APAC EXPERTISE

Global strategies. Local insights.

Precision’s Asia-Pacific specialists bring first-hand experience in clinical operations, regulatory strategy and market access across China, Japan and key markets across the region.